InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Cartesian Therapeutics, Inc.

RNAC Clue Score28
United States Fiscal year ends December CIK 0001453687 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Emily English
30 Dec 2025
Chief Operations Officer
Exercised, kept
7,500
$3.30
$24.75K
Emily English
28 Nov 2025
Chief Operations Officer
Exercised, kept
7,500
$3.30
$24.75K
Emily English
12 May 2025
Chief Operations Officer
Exercised, kept
7,500
$3.30
$24.75K
Emily English
15 Apr 2025
Chief Operations Officer
Exercised, kept
7,500
$3.30
$24.75K
Christopher M Jewell
10 Jan 2025
Chief Scientific Officer
Exercised, kept
9,000
$3.23
$29.07K
Emily English
26 Dec 2024
SVP, Head of Manufacturing
Exercised, kept
7,650
$3.30
$25.25K
Christopher M Jewell
20 Nov 2024
Chief Scientific Officer
Exercised, kept
14,000
$3.23
$45.22K
Timothy A Springer
26 Mar 2024
Director
Exercised, kept indirect
1,970,443
$1.46
$2.88M
Timothy C Barabe
14 Jan 2022
Director
Exercised, kept
10,000
$2.10
$21.00K
Takashi Kei Kishimoto
7 May 2021
Chief Scientific Officer
Exercised, kept
13,629
$2.77
$37.75K
Lloyd P. Johnston
11 Feb 2021
COO and SVP, R&D
Exercised, kept
44,871
$0.63
$28.27K
Takashi Kei Kishimoto
23 Oct 2020
Chief Scientific Officer
Exercised, kept
30,000
$2.77
$83.10K
Timothy C Barabe
24 Jun 2020
Director
Exercised, kept
32,840
$1.46
$47.95K
Lloyd P. Johnston
16 Jan 2020
COO and SVP, R&D
Exercised, kept
5,128
$0.47
$2.41K
Lloyd P. Johnston
23 Jul 2019
COO and SVP, R&D
Exercised, kept
10,000
$0.47
$4.70K
Takashi Kei Kishimoto
7 Jan 2019
Chief Scientific Officer
Exercised, kept
36,114
$2.77
$100.04K
Timothy C Barabe
27 Mar 2017
Director
Exercised, kept
2,492
$11.00
$27.41K
Omid Farokhzad
23 Mar 2017
Director
Exercised, kept
8,019
$7.02
$56.29K
Omid Farokhzad
23 Mar 2017
Director
Exercised, kept
51,981
$3.44
$178.81K
Show all 244 transactions →

What was left out

Form 4 filings counted 335
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 31
Sales at will 82
Transactions with no price 1
Shares from compensation/vesting 59,403,783
Sales filed before the plan box existed 65
History held since 23 Jun 2016